Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Mease, Philip [1 ,2 ]
Tillett, William [3 ,4 ]
de Wit, Maarten [5 ]
Gossec, Laure [6 ]
Husni, M. Elaine [7 ]
Proft, Fabian [9 ,10 ]
Ink, Barbara [8 ,11 ]
Bajracharya, Rajan [11 ]
Coarse, Jason [12 ]
Lambert, Jeremy [13 ]
Coates, Laura [14 ]
Gottlieb, Alice [15 ]
机构：
[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Royal Natl Hosp Rheumat Dis, Bath, England
[4] Univ Bath, Dept Life Sci, Ctr Therapeut Innovat, Bath, England
[5] Stichting Tools, Patient Res Partner, Amsterdam, Netherlands
[6] Sorbonne Univ, Paris, France
[7] Cleveland Clin, Cleveland, OH USA
[8] Charite Univ Med Berlin, Berlin, Germany
[9] Free Univ Berlin, Berlin, Germany
[10] Humboldt Univ, Berlin, Germany
[11] UCB Pharma, Slough, England
[12] UCB Pharma, Morrisville, NC USA
[13] UCB Pharma, Colombes, France
[14] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[15] Icahn Sch Med Mt Sinai, Dept Dermatol, Seattle, WA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2368
引用
收藏
页码：4789 / 4792
页数：4
相关论文
共 50 条
  • [21] Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two Year Results from a Phase 3 Trial
    Helliwell, Philip S.
    Lespessailles, Eric
    Shuler, Catherine
    Mallbris, Lotus
    Erickson, Janelle
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [22] IXEKIZUMAB PROVIDES SUSTAINED IMPROVEMENT IN SIGNS AND SYMPTOMS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: TWO YEAR RESULTS FROM A PHASE 3 TRIAL
    Helliwell, P.
    Lespessailles, E.
    Shuler, C. L.
    Mallbris, L.
    Erickson, J.
    Fleischmann, R.
    Moyano, Sebastian
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S159 - S159
  • [23] Early and Sustained Modified Psarc Response in Psoriatic Arthritis Patients Treated with Ustekinumab: Results from 2 Phase 3 Studies
    McInnes, Iain B.
    Ritchlin, Christopher T.
    Rahman, Proton
    Puig Sanz, Lluis
    Gottlieb, Alice B.
    Li, Shu
    Song, Michael
    Randazzo, Bruce
    Wang, Yuhua
    Mendelsohn, Alan M.
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S685 - S686
  • [24] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 4-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
    McInnes, Iain B.
    Kirkham, Bruce
    Nash, Peter
    Rahman, Proton
    Gottlieb, Alice B.
    Ding, Kevin
    Pricop, Luminita
    RHEUMATOLOGY, 2019, 58
  • [25] BIMEKIZUMAB TREATMENT RESULTED IN IMPROVEMENTS IN FATIGUE AND PAIN IN BIOLOGIC DMARD-NAIVE OR TNFI-IR PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED 16-WEEK RESULTS FROM TWO PHASE 3 RANDOMISED, PLACEBO-CONTROLLED STUDIES
    Rischmueller, Maureen
    Husni, M. Elaine
    Mease, Philip J.
    Merola, Joseph F.
    Behrens, Frank
    Favalli, Ennio G.
    McGonagle, Dennis
    Tillett, William
    Tsuji, Shigeyoshi
    Ink, Barbara
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Gossec, Laure
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 26 - 26
  • [26] SECUKINUMAB PROVIDES RAPID AND SUSTAINED IMPROVEMENTS IN SUBGROUP ANALYSES OF JOINT TENDERNESS AND SWELLING IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 FUTURE 5 STUDY
    McInnes, Iain
    Chinoy, Hector
    Asquith, Darren
    White, Abigail
    Gaillez, Corine
    RHEUMATOLOGY, 2021, 60
  • [27] SECUKINUMAB PROVIDES RAPID AND SUSTAINED PAIN RELIEF IN PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE FUTURE 2 STUDY
    McInnes, I. B.
    Mease, P. J.
    Schett, G.
    Kirkham, B.
    Strand, V.
    Williams, N.
    Fox, T.
    Pricop, L.
    Jugl, S.
    Gandhi, K. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 675 - 675
  • [28] SECUKINUMAB PROVIDES RAPID AND SUSTAINED PAIN RELIEF IN PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE FUTURE 2 STUDY
    Mease, P. J.
    McInnes, I. B.
    Schett, G.
    Kirkham, B.
    Strand, V.
    Williams, N.
    Fox, T.
    Pricop, L.
    Jugl, S.
    Gandhi, K. K.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S116 - S117
  • [29] Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two-Year Results from a Phase 3 Trial
    Helliwell, Philip
    Lespessailles, Eric
    Shuler, Catherine
    Mallbris, Lotus
    Erickson, Janelle
    Fleischmann, Roy
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 998 - 999
  • [30] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM FUTURE 1 AND FUTURE 2
    Strand, V.
    FitzGerald, O.
    Coates, L. C.
    Walsh, J. A.
    Canete, J. D.
    Bhosekar, V.
    Pricop, L.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 688 - 688
12345